Drug intelligence / Profile preview

shenhuang

Development stage: Unknown
Lead developer: Beijing Tcmages Pharmaceutical
Administration: Oral, Topical

Overview

Shenhuang is a traditional Chinese herbal medicine available in multiple formulations including granules, plaster, and powder. Each formulation contains similar herbal ingredients but is used in different applications. The main components typically include Panax ginseng, Rheum palmatum, and other herbs. It has been studied for treating COVID-19, reducing chemotherapy side effects, and treating inflammatory conditions.

Other names: Shenhuang GranuleShenhuang PlasterShenhuang PowderSHGSHP

Targets

NSP13 (SARS-CoV-2 helicase)MMP9 (Matrix metalloproteinase-9)MDM2 (Mouse double minute 2 homolog)IL8 (C-X-C Motif Chemokine Ligand 8)HSP90AA1 (Heat shock protein HSP90-alpha)DNMT1 (DNA (cytosine-5)-methyltransferase 1)IFNG (Interferon gamma)ABCB1 (P-glycoprotein)

Beyond the preview

Go deeper on shenhuang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on shenhuang.

Explore the full profile